NCT01881763.

Study name	Ketamine as an augmentation strategy for electroconvulsive therapy (ECT) in depression
Methods	Double‐blind, parallel randomised controlled trial
Participants	DSM‐IV unipolar or bipolar depression, 18‐70 years HRSD > 21 pre‐treatment MADRS > 19 at screening
Interventions	Ketamine versus methohexital (both IV)
Outcomes	Time to achieve remission (HRSD‐24) Cognitive side effects
Starting date	June 2010
Contact information	Contact: Styliani Kaliora, M.D. skaliora@nshs.edu
Notes	Recruiting